每经记者｜张蕊 每经编辑｜陈柯名 魏官红 记者|张蕊 编辑|陈柯名 魏官红 杜恒峰 校对|程鹏 工业和信息化部等八部门日前联合印发《中药工业高质量发展实施方案（2026—2030年）》（以下简称《方案》）。 《方案》明确，到2030年，中药工业全产业链协同发展体系初步形成，重点中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批 关键技术取得突破，产业协同创新水平显著提高。培育一批引领带动能力突出的中药工业领航企业，培育60个高标准中药原料生产基地。协同体系更加健 全，中药材种植加工、中药研发生产、流通服务等上下游各环节协同更加紧密，建设5个中药工业守正创新中心。 同时，创新产品持续涌现，推动一批中药创新药获批上市，新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药。数智化、绿色化转 型升级取得突破，制修订10项中药工业数智技术相关行业标准，推动建设一批数智化创新载体和公共服务平台，支持企业开展数智化改造提升，发布20个 数智化转型升级典型案例，建设20个智能工厂、培育10个绿色工厂。 中药企业需构建以临床价值 事实上，近年来，中药行业在政策支持下迎来快速发展。华福证券研报显示 ...

2月5日，工业和信息化部等八部门正式对外发布《中药工业高质量发展实施方案（2026—2030年）》 （以下简称《实施方案》）。其中提出，到2030年，中药工业全产业链协同发展体系初步形成,重点中 药原料持续稳定供应能力进一步增强，数智化绿色化水平明显提升，一批关键技术取得突破，产业协同 创新水平显著提高。 同时，《实施方案》重点围绕发展质量、协同体系、创新产品、数智化绿色化转型升级等方面设置了到 2030年具体的任务目标，其中包括，培育一批引领带动能力突出的中药工业领航企业，培育60个高标准 中药原料生产基地；建设5个中药工业守正创新中心；推动一批中药创新药获批上市，新培育10个中成 药大品种，推动一批医疗机构中药制剂转化为中药创新药；制修订10项中药工业数智技术相关行业标 准，发布20个数智化转型升级典型案例，建设20个智能工厂、培育10个绿色工厂。 中医药是中华文明的瑰宝，中药工业是中医药现代化发展的重要支撑。围绕主要目标，工业和信息化部 消费品工业司介绍，《实施方案》以稳定供应、协同创新、智能制造、产品推广、服务体系构建为抓 手，统筹推进六个方面共15项任务。 同时，在实施原料提质稳供行动方面，《实施方 ...

Core Viewpoint - The implementation plan for the high-quality development of the traditional Chinese medicine (TCM) industry from 2026 to 2030 aims to establish a collaborative development system across the entire industry chain, enhance the supply capacity of key TCM raw materials, and promote digital and green transformation [1][2]. Group 1: Development Goals - By 2030, a collaborative development system for the TCM industry will be initially formed, with significant improvements in the supply capacity of key raw materials and advancements in digital and green levels [1]. - The plan sets specific tasks to improve the quality of development, enhance the scale and efficiency of the TCM industry, and cultivate 60 high-standard TCM raw material production bases [1][2]. Group 2: Collaborative System - The plan emphasizes the need for tighter collaboration among various segments of the TCM industry, including planting, processing, research, production, and distribution [1]. - It aims to establish five innovation centers for the TCM industry to foster collaborative innovation [2]. Group 3: Innovation and Product Development - The plan encourages the approval and market launch of innovative TCM drugs, with a target to cultivate 10 major new varieties of traditional Chinese medicine [1][3]. - It aims to transform a number of TCM formulations from medical institutions into innovative TCM drugs [1]. Group 4: Digital and Green Transformation - The plan includes the revision of 10 industry standards related to digital technology in the TCM sector and the establishment of smart factories and green factories [2]. - It supports enterprises in digital transformation and promotes the construction of public service platforms for innovation [2]. Group 5: National Medicine and Market Promotion - The plan focuses on revitalizing the national medicine industry by developing new products based on unique ethnic medicine techniques and establishing quality control systems [3]. - It aims to enhance the clinical and market value of traditional Chinese medicine products and create a unified market for TCM decoction pieces [3]. Group 6: Enterprise Development - The plan promotes a fair competitive environment for TCM enterprises and encourages collaboration between large and small companies [3]. - It supports international cooperation and the registration of competitive TCM products in global markets to enhance international competitiveness [3].

2月5日，工业和信息化部等八部门印发《中药工业高质量发展实施方案（2026—2030年）》（以下简称 《实施方案》）。 《实施方案》提出了未来五年的发展目标：到2030年，中药工业全产业链协同发展体系初步形成，重点 中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业 协同创新水平显著提高。 设置四大目标 根据工业和信息化部消费品工业司披露的解读，《实施方案》着力推进产业政策、监管政策、医保政策 和临床使用政策的有效协同；充分发挥地方政府发展中药工业的积极性，鼓励各地因地制宜先行先试； 将原料的持续稳定供应作为产业链供应链稳定的"牛鼻子"；将支持中药工业龙头企业发展壮大、不断提 高行业集中度作为重中之重。 《实施方案》重点围绕发展质量、协同体系、创新产品、数智化绿色化转型升级等方面设置了具体的任 务目标。 一是发展质量明显提高，中药工业规模效益稳步提升，产业集约化程度明显提高，质量管理水平显著提 升，培育一批引领带动能力突出的中药工业领航企业，培育60个高标准中药原料生产基地。 二是协同体系更加健全，中药材种植加工、中药研发生产、流通服务等上下游各环节协同更加紧密，建 设 ...

此外，主要内容还包括整理特色炮制技术、方剂配伍和用药规范，建立完善质量控制体系；开发优 势民族药新产品，培育民族药名品；全方位推动中成药产品临床价值和市场价值双提升；加强中药工业 国际交流合作，鼓励开展优势中成药产品国际注册等。 新华社北京2月5日电（记者周圆）记者5日获悉，工业和信息化部等八部门日前联合印发《中药工 业高质量发展实施方案（2026—2030年）》，提出到2030年，中药工业全产业链协同发展体系初步形 成，重点中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突 破，产业协同创新水平显著提高。 主要目标还包括，到2030年，培育一批引领带动能力突出的中药工业领航企业，培育60个高标准中 药原料生产基地；建设5个中药工业守正创新中心；推动一批中药创新药获批上市，新培育10个中成药 大品种，推动一批医疗机构中药制剂转化为中药创新药；制修订10项中药工业数智技术相关行业标准， 发布20个数智化转型升级典型案例，建设20个智能工厂、培育10个绿色工厂。 方案以稳定供应、协同创新、智能制造、产品推广、服务体系构建为抓手，统筹推进六个方面共15 项任务，包括加快制修订中药材生 ...

Core Insights - The Ministry of Industry and Information Technology and eight other departments have issued the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)", aiming to establish a collaborative development system for the entire industry chain by 2030 [1] - The plan emphasizes enhancing the stable supply capacity of key traditional Chinese medicine raw materials, improving digital and green transformation levels, and achieving breakthroughs in key technologies [1] - The initiative aims to cultivate 60 high-standard traditional Chinese medicine raw material production bases and establish five innovation centers for the traditional Chinese medicine industry [1] Market-Related Areas - The policy encourages the use of modern scientific technology and traditional Chinese medicine research methods to study the efficacy and mechanisms of traditional Chinese medicine, which will lead to increased R&D investment and accelerated product iteration [1] - The continuous implementation of national and provincial standards for traditional Chinese medicine granules and slices will unify industry standards, posing short-term cost control challenges for some companies but ultimately benefiting larger enterprises with comprehensive industry chain advantages [2] - The current policy environment supports the inheritance and innovation of traditional Chinese medicine culture, providing a favorable market for the value return of branded traditional Chinese medicine [2]

全文如下： 中药工业高质量发展实施方案（2026-2030年） 2月5日，工信部等八部门印发《中药工业高质量发展实施方案（2026—2030年）》，方案提 出，到2030年，中药工业全产业链协同发展体系初步形成，重点中药原料持续稳定供应能力进 一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业协同创新水平显著提 高。发展质量明显提高，中药工业规模效益稳步提升，产业集约化程度明显提高，质量管理水 平显著提升，培育一批引领带动能力突出的中药工业领航企业，培育60个高标准中药原料生产 基地。协同体系更加健全，中药材种植加工、中药研发生产、流通服务等上下游各环节协同更 加紧密，建设5个中药工业守正创新中心。创新产品持续涌现，推动一批中药创新药获批上 市，新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药。数智化、绿色 化转型升级取得突破，制修订10项中药工业数智技术相关行业标准，推动建设一批数智化创新 载体和公共服务平台，支持企业开展数智化改造提升，发布20个数智化转型升级典型案例，建 设20个智能工厂、培育10个绿色工厂。 中医药是中华文明的瑰宝，中药工业是中医药现代化发展的重要支撑， ...

Core Viewpoint - The article discusses the "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" released by the Ministry of Industry and Information Technology and eight other departments, aiming to enhance the TCM industry through innovation, quality improvement, and sustainable development by 2030 [1][2]. Group 1: Policy Goals - By 2030, a collaborative development system for the entire TCM industry chain will be formed, with enhanced supply capabilities for key TCM raw materials and significant improvements in digitalization and greening levels [2][3]. - The plan aims to cultivate 60 high-standard TCM raw material production bases and support the approval of innovative TCM drugs, including the development of 10 new major TCM products [1][2]. Group 2: Key Tasks - Establish high-standard TCM raw material production bases, focusing on key raw material varieties and leveraging financial and technological advantages [3][4]. - Support the development of modern seed industries for TCM materials and enhance the supply monitoring and information service platform for TCM raw materials [3]. Group 3: Innovation and Technology - Strengthen the transformation and application of scientific achievements in the TCM field, fostering new productive forces in the industry [5][6]. - Utilize AI and big data to create knowledge graphs for classic formulas and enhance research capabilities in TCM pharmacology [6][7]. Group 4: Development of Ethnic Medicine - Promote the modernization of ethnic medicine, focusing on unique therapeutic effects and traditional practices, while establishing quality control systems for ethnic medicinal materials [7][8]. - Encourage the development of new products based on ethnic medicine and support collaboration among enterprises and research institutions [7]. Group 5: Market and Brand Development - Enhance the protection of intellectual property for traditional brands and improve production processes for existing TCM products to increase clinical and market value [8][9]. - Foster a unified and regulated market for TCM products, promoting high-quality and cost-effective offerings [8][9]. Group 6: Enterprise Development - Create a fair competitive environment to stimulate the potential and innovation of TCM enterprises, supporting the establishment of development funds and financial services for the industry [9][10]. - Encourage the cultivation of leading enterprises with ecological leadership and core competitiveness, promoting collaborative development across the industry chain [9][10].

Core Viewpoint - The Ministry of Industry and Information Technology, along with eight other departments, has issued the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)", aiming to establish a collaborative development system for the entire traditional Chinese medicine (TCM) industry chain by 2030 [1] Group 1: Development Goals - By 2030, the TCM industry aims to enhance the stable supply capacity of key TCM raw materials and significantly improve digitalization and greening levels [1] - A number of key technologies are expected to achieve breakthroughs, leading to a notable increase in collaborative innovation levels within the industry [1] - The quality of development in the TCM industry is projected to improve significantly, with steady growth in scale and efficiency, and a marked increase in industrial intensification [1] Group 2: Industry Structure and Innovation - The plan includes the cultivation of 60 high-standard TCM raw material production bases and the establishment of five TCM industrial innovation centers [1] - There is an emphasis on the continuous emergence of innovative products, with the goal of approving a number of TCM innovative drugs for market release and nurturing ten major varieties of traditional Chinese medicine [1] - The transformation and upgrading towards digitalization and greening are expected to achieve breakthroughs, including the revision of ten industry standards related to TCM digital technology [1] Group 3: Infrastructure and Support - The initiative will support enterprises in digital transformation and enhancement, with the publication of 20 typical cases of digital transformation and the construction of 20 smart factories and 10 green factories [1]

Core Viewpoint - The Ministry of Industry and Information Technology and eight other departments have issued the "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)", aiming to establish a collaborative development system for the entire industry chain of traditional Chinese medicine by 2030, enhancing supply capabilities, innovation, and quality management [1][5][7]. Summary by Sections Overall Requirements - The plan emphasizes the integration of traditional Chinese medicine with modern technology and aims to enhance the resilience and stability of the supply chain [6][7]. Key Tasks - **Raw Material Quality Improvement and Stable Supply**: Establish high-standard production bases for key raw materials, enhance initial processing capabilities, and improve quality standards [8][9]. - **Collaborative Innovation**: Strengthen the collaborative innovation system by integrating resources from various sectors, focusing on modern clinical needs and addressing technological bottlenecks [9][10]. - **Manufacturing Capability Enhancement**: Promote standardized production and quality control in traditional Chinese medicine, and encourage the adoption of intelligent and green manufacturing technologies [12][13]. National Drug Industry Revitalization - Focus on discovering and modernizing ethnic medicine resources, ensuring stable supply and clinical demand through targeted research and development [14]. Promotion of Traditional Chinese Medicine Products - Enhance the quality and market presence of traditional Chinese medicine products, including the development of new products and leveraging e-commerce platforms for better consumer access [15][16]. Cultivation of Excellent Enterprises - Support the growth of leading enterprises in the traditional Chinese medicine sector, encourage international market expansion, and enhance brand recognition through global cooperation [17][18].